Thiol/disulphide balance and ischemia modified albumin levels in relapsed brucellosis patients

Abstract

Objectives: In the study, it was aimed to determine the Thiol/Disulphide profile in patients with relapsed brucellosis and the relationship between Ischemia Modified Albumin (IMA) Levels and Thiol/Disulphide profile.

Methods: Native thiol, Total thiol, Disulphide, Disulphide/Native thiol, Disulphide/Total thiol, IMA levels were measured in forty patients with relapsed brucellosis and healthy control group by using the newly developed method in this cross-sectional study.

Results: There was no statistically significant difference in patients with relapse brucellosis despite the fact that it was lower than total thiol control group (p > 0.05). Disulphide was detected high in patients with brucellosis but no statistically significant difference was found (p > 0.05). Native thiol and total thiol ratios of disulphide were found to be statistically higher in patients with relapsed brucellosis (p < 0.05). In addition, the ratio of native thiol and native thiol to total thiol was statistically lower than the control group (p < 0.05). The levels of IMA were statistically significant in patients with relapsed brucellosis compared to the control group (p <0.05). There was a statistically significant positive correlation between IMA values and Disulphide and Disulphide/Native thiol, Disulphide/Total thiol, Native thiol/Total thiol ratios (r=0.514, r=0.527, r=0.527, r=0.527; respectively).

Conclusions: It is known that the response of brucellosis treatment can be followed up with oxidative stress markers and it can also be used as a relapse indicator in our study.

Keywords

• Relapse brucellosis
• thiol/disulphide
• ischemia modified albumin

References

1. 1. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006;6:91-9.
2. 2. DelVecchio VG, Kapatral V, Redkar RJ, Patra G, Mujer C, Los T, et al. The genome sequence of the facultative intracellular pathogen Brucella melitensis. Proc Natl Acad Sci USA 2002;99:443-8.
3. 3. Jiang X, Leonard B, Benson R, Baldwin CL. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cell Immunol 1993;151:309-19.
4. 4. Serefhanoglu K, Taskin A, Turan H, Ergin Timurkaynak F, Arslan H, Erel Ö. Evaluation of oxidative status in patients with brucellosis. Braz J Infect Dis 2009;13:249-51.
5. 5. Kaplan M, Ates I, Yuksel M, Ozin YO, Alisik M, Erel O, et al. Thiol/disulphide homeostasis in celiac disease. World J Gastrointest Pharmacol Ther 2017;8:120-6.
6. 6. Sanrı US, Özsin KK, Toktaş F, Balcı AB, Üstündağ Y, Huysal K, et al. The effect of thiol-disulfide homeostasis in patients undergoing on-pump coronary artery bypass grafting. Turk Gogus Kalp Damar Cerrahisi Derg 2019;27:484-92.
7. 7. Topuz M, Kaplan M, Akkus O, Sen O, Yunsel HD, Allahverdiyev S, et al. The prognostic importance of thiol/disulfide homeostasis in patients with acute pulmonary thromboembolism. Am J Emerg Med 2016;34:2315-9.
8. 8. Ivanov AV, Alexandin VV, Paltsyn AA, Nikiforova KA, Virus ED, Luzyanin BP, et al., Plasma low-molecular-weight thiol/disulphide homeostasis as an early indicator of global and focal cerebral ischaemia. Redox Report 2017;22:460-6.

9. 9. Murray HW, Teitelbaum RF. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J Infect Dis 1992;165:513-7.
10. 10. Kara SS, Erel O, Demirdag TB, CuraYayla BC, Gulhan B, Neselioglu S, et al. Alteration of thiol-disulphide homeostasis in acute tonsillopharyngitis. Redox Report 2017;22:205-9.
11. 11. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000;19:311-5.
12. 12. Prashanth A, Anand U. Clinical significance of ischemia modified albumin in critically ill patients with sepsis. Indian J Clin Biochem 2015;30:194-7.
13. 13. Özsin KK, Balci AB, Sanri US, Guvenc O, Yavuz S. Levels of ischemia: modified albumin in patients undergoing on-pump coronary artery bypass. J Coll Physicians Surg Pak 2020;30:561-7
14. 14. Roushan MRH, Amiri MJS, Janmohammadi N, Hadad MS, Javanian M, Baiani M, et al. Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: a randomized clinical trial. J Antimicrob Chemother 2010;65:1028-35.
15. 15. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 2014;47:326-32.
16. 16. Roushan MRH, Moulana Z, Afshar ZM, Ebrahimpour S. Risk factors for relapse of human brucellosis. Glob J Health Sci 2015;8:77-82.
17. 17. Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanisms in patients with Behcet's syndrome. J Am Coll Cardiol 2001;37:517-20.
18. 18. Babior BM. Phagocytes and oxidative stress. Am J Med. 2000;109:33-44.
19. 19. Tufan ZK, Hasanoglu I, Kolgelier S, Alisik M, Ergin M, Yilmaz GR, et al. A retrospective controlled study of thiol disulfide homeostasis as a novel marker in Crimean Congo hemorrhagic fever. Redox Report 2017;22:241-5.
20. 20. Horoz M, Bolukbas C, Bolukbas FF, Aslan M, Koylu AO, Selek S, et al. Oxidative stress in hepatitis C infected end-stage renal disease subjects. BMC Infect Dis 2006;6:114.
21. 21. Draganov D, Teiber J, Watson C, Bisgaier C, Nemzek J, Remick S, et al. PON1 and oxidative stress in human sepsis and an animal model of sepsis. Adv Exp Med Biol 2010;660:89-97.
22. 22. Bayraktar N, Kilic S, Bayraktar MR, Aksoy N. Lipid peroxidation and antioxidant enzyme activities in cancerous bladder tissue and their relation with bacterial infection: a controlled clinical study. J Clin Lab Anal 2010;24:25-30.
23. 23. Young I, Woodside J. Antioxidants in health and disease. J Clin Pathol 2001;54:176-86.
24. 24. Ghezzi P, Bonetto V, Fratelli M. Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxid Redox Signal 2005;7:964-72.
25. 25. Kolgelier S, Ergin M, Demir LS, Inkaya AC, Aktug Demir N, Alisik M, et al. Impaired thiol-disulfide balance in acute brucellosis. Jpn J Infect Dis 2017;70:258-62.
26. 26. Karaagac L, Koruk ST, Koruk I, Aksoy N. Decreasing oxidative stress in response to treatment in patients with brucellosis: could it be used to monitor treatment? Int J Infect Dis 2011;15:346-9.
27. 27. Gunduz A, Turedi S, Mentese A, Altunayoglu V, Turan I, Karahan SC, et al. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med 2008;26:874-8.
28. 28. Guntas G, Sahin A, Duran S, Kahraman R, Duran I, Sonmez C, et al. Evaluation of ischemia-modified albumin in patients with inflammatory bowel disease. Clin Lab 2017;63:341-7.